HeartLung AI will showcase seven abstracts at ESC 2025 on AI-CVD™, including novel AI-CAC™ for earlier, more sensitive heart disease...

FDA Breakthrough-designated AutoChamber™ AI uses routine CT scans to detect early cardiac chamber enlargement and prevent serious heart...

HeartLung's medical leadership featured on Imaging Wire Show to discuss breakthrough new AI for opportunistic osteoporosis screening....

AI-based LV volume from CAC scans predicts heart failure over 15 years as accurately as MRI, enabling early detection from routine CT...

HOUSTON, TX, UNITED STATES, July 8, 2025 / EINPresswire.com / -- HeartLung.AI , a leader in AI-powered medical imaging solutions for...

HeartLung Technologies partners with Capitol Imaging Services to offer Artificial Intelligence-Enabled Osteoporosis Screening (AutoBMD™ AI and AutoChamber™ AI) as an add-on to CT Scans in Alabama.

Dr. Robert A. Kloner's latest musical endeavor, "Fillmore Station," is a blend of piano-based neo-classical and new age music.

Research shows HeartLung.AI’s AI-CVD™ improves traditional calcium scores in predicting heart disease risk and all-cause mortality

CMS has approved a new HCPCS code for AutoChamber™ AI reporting cardiac chambers volume and left ventricular mass in existing CT scans.

HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board.

HeartLung showcases AI innovations at BMEII 2025, advancing healthcare with three scientific presentations.

HeartLung Technologies to launch AutoChamber™ AI at ACC 2025 and begin offering the AI services to healthcare providers

HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge

SimonMed Imaging partners with HeartLung.AI to roll out AutoBMD™ AI for osteoporosis screening, enhancing preventive healthcare.

HeartLung Technologies welcomes Dr. Robert A. Kloner to the Advisory Board. Discover his contributions to heart health and his music.

2024 was a monumental year for HeartLung Technologies. With that being said, we have exciting developments for 2025!

HeartLung collaborator, Dr. Claudia Henschke, has been honored with the prestigious Scientific Excellence Award at #RSNA2024!

HeartLung is the only AI company participating in RSNA 2024 as a scientific presenter of research studies and as an industry exhibitor

Innovative AI-enabled research studies led by HeartLung’s founder Dr. Morteza Naghavi show life-saving potential for primary prevention...

The First AI that Enables Opportunistic Detection of Hidden Heart Disease in Millions of CT Scans SUMMARY: HeartLung Technologies (...